CI Investments Inc
DXCM icon

CI Investments Inc’s DexCom DXCM Stock Holding History

CI Investments Inc’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$86.7M Buy
1,287,663
+415,085
+48% +$27.7M 0.28% 71
2026
Q1 		$54.8M Sell
872,578
-13,138
-1% -$915K 0.27% 90
2025
Q4 		$58.8M Buy
885,716
+337,584
+62% +$21.8M 0.26% 87
2025
Q3 		$36.9M Buy
548,132
+162,100
+42% +$12.8M 0.13% 130
2025
Q2 		$33.7M Buy
386,032
+169,059
+78% +$13.3M 0.13% 141
2025
Q1 		$14.8M Buy
216,973
+1,429
+0.7% +$117K 0.06% 190
2024
Q4 		$16.8M Buy
215,544
+97,683
+83% +$7.23M 0.06% 191
2024
Q3 		$7.9M Buy
117,861
+103,164
+702% +$8.47M 0.03% 261
2024
Q2 		$1.67M Sell
14,697
-3,889
-21% -$492K 0.01% 352
2024
Q1 		$2.58M Buy
18,586
+5,382
+41% +$677K 0.01% 327
2023
Q4 		$1.64M Sell
13,204
-868
-6% -$88.7K 0.01% 340
2023
Q3 		$1.31M Sell
14,072
-130,984
-90% -$14.8M 0.01% 351
2023
Q2 		$18.6M Buy
145,056
+135,866
+1,478% +$16.4M 0.09% 176
2023
Q1 		$1.07M Buy
9,190
+2,650
+41% +$297K 0.01% 366
2022
Q4 		$741K Sell
6,540
-287
-4% -$31.5K ﹤0.01% 394
2022
Q3 		$550K Buy
6,827
+503
+8% +$42.6K ﹤0.01% 417
2022
Q2 		$471K Sell
6,324
-1,648
-21% -$150K ﹤0.01% 478
2022
Q1 		$1.02M Sell
7,972
-804
-9% -$87.9K ﹤0.01% 432
2021
Q4 		$1.18M Buy
8,776
+328
+4% +$47.1K ﹤0.01% 434
2021
Q3 		$1.16M Buy
8,448
+2,284
+37% +$288K ﹤0.01% 443
2021
Q2 		$658K Sell
6,164
-2,544
-29% -$244K ﹤0.01% 569
2021
Q1 		$782K Buy
8,708
+2,536
+41% +$238K ﹤0.01% 434
2020
Q4 		$570K Sell
6,172
-4,608
-43% -$411K ﹤0.01% 468
2020
Q3 		$1.11M Buy
10,780
+616
+6% +$64.4K 0.01% 353
2020
Q2 		$1.03M Buy
10,164
+444
+5% +$39.7K 0.01% 349
2020
Q1 		$654K Sell
9,720
-8,140
-46% -$507K ﹤0.01% 369
2019
Q4 		$977K Buy
17,860
+17,692
+10,531% +$839K 0.01% 364
2019
Q3 		$6K Buy
+168
New +$6.53K ﹤0.01% 583

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

CI Investments Inc's DXCM Position: Q2 2026 in Review

CI Investments Inc increased its DexCom (DXCM) stake by 48% in Q2 2026, buying an estimated $27.7M and bringing the position to 1,287,663 shares worth $86.7M. The position accounts for 0.28% of the portfolio, ranked #71.

CI Investments Inc first reported a position in DXCM in Q3 2019 and has held it in 28 quarters since. 966 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • CI Investments Inc held 1,287,663 shares of DexCom worth $86.7M as of Q2 2026.
  • CI Investments Inc bought 415,085 DexCom shares in Q2 2026, an estimated $27.7M.
  • DexCom made up 0.28% of CI Investments Inc's portfolio in Q2 2026, its #71 holding.
  • CI Investments Inc first reported a position in DexCom in Q3 2019 and has held it in 28 quarters since.
  • 966 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on CI Investments Inc's 13F filing for Q2 2026, filed 13 Aug 2026.